Day: July 15, 2025
Aalberts today reports that it has repurchased 2,500 of its own shares in the period from 07 July 2025, up to and including 11 July 2025, for an amount of EUR 78,823.16, so at an average share price of EUR 31.53.
This is part of the share buyback programme as announced on 27 February 2025, for a total amount of EUR 75 million. The repurchase of shares commenced on 28 February 2025 and will be completed no later than 24 October 2025. It is intended that the shares will be cancelled following repurchase.
Up to and including 11 July 2025, a cumulative total of 2,002,324 shares was repurchased under the share buyback programme for a total consideration of EUR 59,718,534.
Aalberts has engaged an intermediary to repurchase the Aalberts shares in the open market, during open and closed periods, independent of Aalberts.
The share buyback will...
Mowi ASA (OSE:MOWI): Q2 2025 Trading update
Written by Customer Service on . Posted in Public Companies.
Harvest volumes Q2 2025 (1)Farming Norway
72.5 thousand tonnes
Farming Scotland
24.0 thousand tonnes
Farming Chile
15.5 thousand tonnes
Farming Canada
9.5 thousand tonnes
Farming Ireland
5.0 thousand tonnes
Farming Faroes
4.5 thousand tonnes
Farming Iceland (Arctic Fish)
2.0 thousand tonnes
Total
133.0 thousand tonnes
In connection with the presentation of the Q1 2025 results, Mowi guided a total harvest volume of 130k GWT for Q2 2025 (110k GWT in Q2 2024).
Note:(1) The harvest volumes are provided in gutted weight equivalents (GWT).
Additional information
Operational EBIT for the Group was approx. EUR 189 million in Q2 2025 (NOK 2,206 million / EURNOK 11.67) on strong cost performance. Blended farming cost was EUR 5.39 per kg in the quarter, down from EUR 5.84 in Q2 2024 and EUR 5.89 in Q1 2025.
Total...
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
Written by Customer Service on . Posted in Public Companies.
SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) — PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that Aquablation therapy was assigned a Category I code effective January 1, 2026.
The 2026 Medicare Proposed Physician Fee Schedule (PFS) includes payment rates for a new Category I Current Procedural Terminology (CPT) code related to Aquablation therapy. Category I CPT code 52XX1 will replace Category III CPT code 0421T as the primary code for Aquablation therapy.
“Securing a Category I CPT Code marks a major milestone for PROCEPT, the urology community, and the patients we serve,” said Sham Shiblaq, chief commercial officer of PROCEPT BioRobotics. “This transition recognizes the clinical value...